Description
Stanocyl® is an oral tablet preparation containing stanozolol, a 17α-alkylated derivative of dihydrotestosterone. The molecule is characterised by a pyrazole ring fused to the A-ring of the steroid nucleus, distinguishing it from other 17α-alkylated steroid compounds in the same broad class.
The tablet format is suited to this small-molecule steroid compound for oral administration. In this dosage form, the active substance is provided as a measured unit dose intended for release after ingestion, with the 17α-alkylated structure supporting oral presentation rather than an esterified oil-based injectable format.
Further details on composition, method of use, precautions, possible side effects, contraindications and storage are provided in the package leaflet.